1. Granulocyte-macrophage colony-stimulating factor, a potent adjuvant for polarization to Th-17 pattern: an experience on HIV-1 vaccine model
- Author
-
Mohammad Choopani, Hamid Reza Moozarmpour, Amir Hossein Tajik, Christine Hartoonian, Mehdi Mahdavi, Morteza Kameli, Soophie Olfat, Mohammad Mehdi Adibzadeh, Massoumeh Ebtekar, Roghieh Rahimi, Zuhair Mohammad Hassan, and Mohammad Sadegh Beikverdi
- Subjects
0301 basic medicine ,Microbiology (medical) ,medicine.medical_treatment ,Enzyme-Linked Immunosorbent Assay ,chemical and pharmacologic phenomena ,Lymphocyte proliferation ,HIV Antibodies ,Pathology and Forensic Medicine ,DNA vaccination ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Adjuvants, Immunologic ,Vaccines, DNA ,Animals ,Immunology and Allergy ,Medicine ,Cell Proliferation ,AIDS Vaccines ,Mice, Inbred BALB C ,Vaccines, Synthetic ,biology ,business.industry ,Granulocyte-Macrophage Colony-Stimulating Factor ,General Medicine ,Cytotoxicity Tests, Immunologic ,Virology ,CTL ,030104 developmental biology ,Granulocyte macrophage colony-stimulating factor ,Cytokine ,Immunoglobulin G ,Immunology ,biology.protein ,Cytokines ,Th17 Cells ,Female ,Antibody ,business ,Adjuvant ,030215 immunology ,medicine.drug - Abstract
Cytokines are mediators for polarization of immune response in vaccines. Studies show that co-immunization of DNA vaccines with granulocyte-macrophage colony-stimulating factor (GM-CSF) can increase immune responses. Here, experimental mice were immunized with HIV-1tat/pol/gag/env DNA vaccine with GM-CSF and boosted with recombinant vaccine. Lymphocyte proliferation with Brdu and CTL activity, IL-4, IFN-γ, IL-17 cytokines, total antibody, and IgG1 and IgG2a isotypes were assessed with ELISA. Results show that GM-CSF as adjuvant in DNA immunization significantly increased lymphocyte proliferation and IFN-γ cytokines, but CTL response was tiny increased. Also GM-CSF as adjuvant decreased IL-4 cytokine vs mere vaccine group. IL-17 in the group that immunized with mixture of DNA vaccine/GM-CSF was significantly increased vs DNA vaccine group. Result of total antibody shows that GM-CSF increased antibody response in which both IgG1 and IgG2a increased. Overall, results confirmed the beneficial effect of GM-CSF as adjuvant to increase vaccine immunogenicity. The hallmark result of this study was to increase IL-17 cytokine with DNA vaccine/GM-CSF immunized group. This study for the first time provides the evidence of the potency of GM-CSF in the induction of IL-17 in response to a vaccine, which is important for control of infection such as HIV-1.
- Published
- 2017
- Full Text
- View/download PDF